This volume reviews the evolution of information regarding the epidemiology of DCIS and its
modes of detection as well as treatment options as a function of both clinical trial data and
ongoing investigational therapeutic prospects. Several of the challenging and
clinically-relevant scenarios of DCIS that appear in daily practice is discussed including the
difficulties of distinguishing true DCIS from borderline patterns of other breast diseases and
the therapeutic implications of differentiating these various diagnoses. Particular attention
is paid to pathologic evaluation of DCIS including histologic patterns and the importance of
margin evaluation margin control. The text also explores the data regarding DCIS in medical
research in hereditary susceptibility for breast cancer and race ethnicity-associated
disparities in breast cancer. Written by experts in the field Ductal Carcinoma In Situ and
Microinvasive Borderline Breast Cancer is a comprehensive state-of-the art review of the field
and serves as a valuable resource for clinicians surgeons and researchers with an interest in
breast cancer.
